Healthcare

Accelerating Growth and Enhancing Value for Healthcare

Roth’s Healthcare Team provides financing and strategic advisory services for public and private companies in the life sciences sector. Our clients include both development and commercial stage companies and include companies engaged in the development of novel therapeutic compounds, the application of unique drug discovery and drug delivery technologies, and the development and marketing of biopharmaceuticals, specialty pharmaceuticals, medical devices and diagnostics.

Roth works closely with our clients’ management teams and boards of directors to determine and execute optimal financing strategies. Roth has an extensive track record in executing IPOs, follow-on offerings, PIPEs, registered directs and confidentially marketed public offerings for life sciences companies.

Additionally, Roth also advises our clients on strategic transactions, including mergers, acquisitions, divestitures, reverse mergers, strategic sales, licensing agreements and strategic partnerships, and provides fairness opinions related to such transactions.

Investment Banking

Sector Focus

  • Biotechnology
  • Specialty pharmaceuticals
  • Medical devices
  • Diagnostics

Investment Banking Team

James Antonopoulos

Managing Director & Head of Healthcare Investment Banking

View Profile

John Boris

Managing Director, Investment Banking

View Profile

Benjamin Bowen

Managing Director, Investment Banking

View Profile

Aparna Beeram

Vice President, Investment Banking

View Profile

Select Transactions

View All Transactions

$18,000,000

Biofrontera, Inc.

IPO

Joint Book-Running Manager November 2021

$16,653,000

RenovoRx Inc.

IPO

Sole Book-Running Manager August 2021

$25,000,000

Unicycive Therapeutics, Inc.

IPO

Sole Manager July 2021

$39,970,000

TFF Pharmaceuticals, Inc.

Follow-On

Sole Book-Running Manager March 2021

$52,431,223

KemPharm, Inc.

Follow-On

Sole Manager January 2021

$15,023,000

Applied DNA Sciences, Inc.

Registered Direct

Sole Placement Agent January 2021

$24,795,000

Immunic, Inc.

Follow-On

Lead Placement Agent June 2020

$22,000,000

Delcath Systems, Inc.

Follow-On

Sole Book-Running Manager May 2020

Research

At a Glance

117

Covered companies

5

Analysts

Research Team

Jonathan Aschoff, Ph.D.

Managing Director, Senior Research Analyst

View Profile

Tony Butler, Ph.D.

Managing Director, Senior Research Analyst & Head of Biotechnology Research

View Profile

Scott Henry, CFA

Managing Director, Senior Research Analyst & Head of Pharmaceuticals Research

View Profile

Elemer Piros, Ph.D.

Managing Director, Senior Research Analyst

View Profile

Zegbeh Jallah, Ph.D.

Managing Director, Research Analyst

View Profile